Skip to search formSkip to main contentSkip to account menu

MK 771

Known as: MK-771 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thyrotropin-Releasing Hormone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
First pharmacological characterization of TRH receptors linked to phosphoinositide hydrolysis in GH3 pituitary cells using agonist specificity of eight TRH analogs.
1988
1988
The comparative pharmacology of the behavioral syndromes induced by TRH and by 5-HT in the rat.
1988
1988
Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice
1988
1988
Substance P antagonist-induced spinal cord vasoconstriction: Effects of thyrotropin-releasing hormone and substance P agonists
1984
1984
Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat
1983
1983
In vitro study of frog (Rana ridibunda Pallas) neurointermediate lobe secretion by use of a simplified perifusion system. I. Effect of TRH analogs upon alpha-MSH release.
Review
1982
Review
1982
Regulatory peptides as a source of new drugs — the clinical prospects for analogues of TRH which are resistant to metabolic degradation
Review
1979
Review
1979
On the neuropharmacology of thyrotropin releasing hormone (TRH)
1979
1979
Effects of MK-771 on the isolated amphibian spinal cord: comparison with thyrotropin-releasing hormone.
Topically applied MK-771 (pyro-2-aminoadipyl-histidyl-thiazolidine-4-carboxamide), a novel thyrotropin-releasing hormone (TRH… 
Highly Cited
1978
Highly Cited
1978
Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and a new TRH analog.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)